ArticleCadernos de saude publica2025
["How to get your Doxy-PEP?": vulnerabilities and critical routes encountered by men in the therapeutic itinerary in Brazil].
Article in Cadernos de saude publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Doxy-PEP interest, awareness, and use among sexual and gender minorities in Brazil, Mexico, and Peru: findings from a web-based survey.Lancet regional health. Americas · 2026Article
- Pre-Exposure Prophylaxis Use Among Cisgender and Transgender Adult Entertainment Workers in Brazil.International journal of environmental research and public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the context of doxycycline-based post-exposure prophylaxis (Doxy-PEP) use for the prevention of sexually transmitted infections (STIs) by men who have sex with men (MSM) in Brazil. A qualitative study was conducted with 32 MSM participants, selected on social media. Data was collected by online questionnaires, which included open-ended questions about experiences with Doxy-PEP, access to medications, and interactions with the health care system. Responses were analyzed using the IRaMuTeQ program for descending hierarchical classification and reflective thematic analysis. The results revealed three main categories: (1) access to and management of post-exposure prophylaxis, in which participants reported difficulties in obtaining Doxy-PEP due to prescribing restrictions and lack of information; (2) perceptions and knowledge on risks and prevention, which highlighted a mix of knowledge and misinformation about STIs and prevention strategies; (3) social and behavioral dynamics, demonstrating how social interactions and stigma influence prevention practices. The study also indicated self-medication and drug storage as common practices. The study identified multiple barriers to access and management of Doxy-PEP among MSM in Brazil, influenced by individual, social, and programmatic factors. It is imperative to develop public health strategies that improve access to and information about Doxy-PEP among MSM, as well as approaches that reduce STIs-associated stigma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.